← Open Payments lookup

MICHAEL RUSSO: Open Payments

NPI 1194887125 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,214 in 62 payments from 18 companies in 2025. Trend: 2023 $1,517 · 2024 $1,340 · 2025 $1,214

Food & beverage: $1,213Education: $1
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$212
GlaxoSmithKline, LLC.8$169
ABBVIE INC.11$157
Vanda Pharmaceuticals Inc.7$145
Corcept Therapeutics5$111
Bayer Healthcare Pharmaceuticals Inc.4$81
Novo Nordisk Inc3$57
Lundbeck LLC2$42
Indivior Inc.1$41
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37

Products named: TRELEGY ELLIPTA, BREZTRI, Korlym, VRAYLAR, FANAPT, FARXIGA, Kerendia, REXULTI.

Industry payments across LA — which companies pay providers there.